AMLN Related Analyst PT Change
-
Jefferies Raises Numbers on Amylin Pharmaceuticals (AMLN) On Upside to Bydureon Sales
-
MKM Partners Upgrades Amylin Pharmaceuticals (AMLN) to Neutral
-
Credit Suisse Reinstates Coverage on Amylin Pharmaceuticals (AMLN) at Outperform
-
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Back to AMLN Stock Lookup
